Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
VYNE Therapeutics Inc. (VYNE)
USD0.76
+0.05 (+6.50%)
US NASDAQ Healthcare Biotechnology
Address
520 U.S. Highway 22 8807
Bridgewater, NJ, US
Bridgewater, NJ, US
CEO
David T. Domzalski
Website
vynetherapeutics.com
IPO
2018-01-25
CIK 1566044 ISIN US92941V3087
Description
VYNE Therapeutics Inc. is a pharmaceutical enterprise dedicated to discovering and advancing therapies for immune-mediated inflammatory conditions. Its development portfolio features FCD105, a topical foam formulation that has successfully finished Phase III clinical studies for the management of moderate-to-severe acne vulgaris. Another candidate in its pipeline is FMX114, a combination treatment incorporating tofacitinib, which is currently in early-stage clinical assessment, referred to as a Phase IIa preclinical trial, for addressing mild-to-moderate atopic dermatitis. Additionally, the company is progressing VYN201, a bromodomain and extra-terminal (BET) inhibitor designed to target a range of immuno-inflammatory disorders, notably those affecting the skin. A further asset is VYN202, which comprises BET inhibitor compounds engineered for selective action on bromodomain 2. Established in 2003, the firm was formerly recognized as Menlo Therapeutics Inc. before officially changing its corporate identity to VYNE Therapeutics Inc. in September 2020. The company's principal operations are based in Bridgewater, New Jersey.
News Sentiment (7d)
Based on only 1 article — low confidence
Market Cap & Enterprise Value
Merger & Acquisition History
| Target company | Ticker | Date | Filing |
|---|---|---|---|
| Foamix | FOMX | 2019-12-04 | View |
Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary
Loading…
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
USD0.76
+0.05 (+6.50%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
162.8K
Beta
2.01
Float Shares
13.62M
Free Float %
81.7%
Price Performance
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| -0.06% | +1.52% | +9.82% | +12.91% | +80.40% | +15.50% | -45.08% | -90.67% | -98.97% | -99.97% | -99.97% |
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From
To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
Loading histogram data…
Revenue flow
Revenue by geography
Revenue by segment
From
To
Revenue composition
From
To
By product
By geography
Financial Statements
Select metrics from the tables below to build your comparison.
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
Analyst Consensus (2 ratings, all time)
Buy
Price Targets & DCF
Current price
0.76
Low
5.75
+659.4%
Consensus
5.75
+659.4%
Median
5.75
+659.4%
High
5.75
+659.4%
DCF (Unlevered)
0.47
-38.2%
DCF (Levered)
0.48
-36.9%
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
Ratings Trend (MoM)
33% Bullish
| Rating | 2026-05 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 1 | 0 |
| Hold | 2 | -1 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
Price Target Summary
| Period | # Analysts | Avg Target |
|---|---|---|
| Last Month | — | — |
| Last Quarter | — | — |
| Last Year | — | — |
| All Time | 1 |
5.75
+659.4%
|
Quality scores
Altman Z-Score
-37.65
Distress
Piotroski F-Score
2 / 9
Weak
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
4 / 5
High
Operational MOAT
✗ Below peers
-
Revenue growth Biotechnology: +1.6%+13.8% ★ Q1'26: -57.4% (vs Q1'25)
-
EPS growth Biotechnology: +29.7%+34.0% ★ Q1'26: +58.1% (vs Q1'25)
-
FCF margin FCF growth · Biotechnology: +16.2%-6,128.1% Q1'26: -4,745.3% (vs Q1'25)
-
EBIT margin Biotechnology: +0.0%-4,689.8% Q1'26: -4,437.2% (vs Q1'25)
-
ROIC Biotechnology: -16.1%— Q1'26: +5,245.4% (vs Q1'25)
-
Share dilution Biotechnology: -3.4%+0.4% ★ Q1'26: +0.2% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Biotechnology: 0.16×0.00× Q1'26: 0.00× (vs Q1'25)
Valuation Multiples
From
To
Price Forecast (3Y)
From
To
Theoretical Return — If Invested Today
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
Consensus Estimates
| Metric |
Dec 2017 actual |
Dec 2018 actual |
Dec 2020 actual |
Dec 2021 actual |
Dec 2022 actual |
Dec 2023 actual |
Dec 2024 actual |
Dec 2025 actual |
Dec 2026 2 Rev. Ana. 1 EPS Ana. |
Dec 2027 2 Rev. Ana. 1 EPS Ana. |
Dec 2028 2 Rev. Ana. 1 EPS Ana. |
Dec 2029 1 Rev. Ana. 1 EPS Ana. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue |
4.58M
est: 3.57M (+28.4%)
|
10.64M
est: 10.70M (-0.6%)
|
20.99M
est: 21.43M (-2.0%)
|
931.0K
est: 17.26M (-94.6%)
|
477.0K
est: 366.7K (+30.1%)
|
424.0K
est: 486.0K (-12.8%)
|
501.0K
est: 533.3K (-6.1%)
|
570.0K
est: 600.0K (-5.0%)
|
350.0K
350.0K – 350.0K
-41.7% YoY
|
10.25M
10.25M – 10.25M
+2,828.6% YoY
|
13.60M
13.60M – 13.60M
+32.7% YoY
|
50.00M
50.00M – 50.00M
+267.6% YoY
|
| EBITDA |
-29.59M
est: -3.57M (-729.2%)
|
-54.54M
est: -61.44M (+11.2%)
|
-251.10M
est: -21.43M (-1,071.8%)
|
-38.80M
est: -70.38M (+44.9%)
|
-34.22M
est: -73.77M (+53.6%)
|
-29.26M
est: -486.0K (-5,920.2%)
|
-43.63M
est: -533.3K (-8,081.2%)
|
-26.73M
est: -600.0K (-4,355.3%)
|
-350.0K
-350.0K – -350.0K
+41.7% YoY
|
-10.25M
-10.25M – -10.25M
-2,828.6% YoY
|
-13.60M
-13.60M – -13.60M
-32.7% YoY
|
-50.00M
-50.00M – -50.00M
-267.6% YoY
|
| EBIT |
-29.59M
est: -3.57M (-729.2%)
|
-54.54M
est: -63.13M (+13.6%)
|
-251.44M
est: -21.43M (-1,073.4%)
|
-38.91M
est: -43.38M (+10.3%)
|
-34.30M
est: -39.64M (+13.5%)
|
-29.26M
est: -486.0K (-5,920.2%)
|
-43.64M
est: -533.3K (-8,081.9%)
|
-26.73M
est: -600.0K (-4,355.3%)
|
-350.0K
-350.0K – -350.0K
+41.7% YoY
|
-10.25M
-10.25M – -10.25M
-2,828.6% YoY
|
-13.60M
-13.60M – -13.60M
-32.7% YoY
|
-50.00M
-50.00M – -50.00M
-267.6% YoY
|
| Net Income |
-29.08M
est: -6.53B (+99.6%)
|
-51.45M
est: -59.40M (+13.4%)
|
-255.57M
est: -2.34B (+89.1%)
|
-73.33M
est: -74.41M (+1.5%)
|
-23.21M
est: -32.67M (+28.9%)
|
-28.45M
est: -40.02M (+28.9%)
|
-39.83M
est: -41.06M (+3.0%)
|
-26.48M
est: -26.74M (+0.9%)
|
-25.23M
-25.23M – -25.23M
+5.6% YoY
|
-27.37M
-27.37M – -27.37M
-8.5% YoY
|
-27.37M
-27.37M – -27.37M
+0.0% YoY
|
-113.34M
-113.34M – -113.34M
-314.1% YoY
|
| SGA |
5.17M
est: 84.44M (-93.9%)
|
12.19M
est: 253.16M (-95.2%)
|
89.54M
est: 506.99M (-82.3%)
|
20.30M
est: 408.37M (-95.0%)
|
16.39M
est: 8.68M (+88.9%)
|
13.38M
est: 12.97M (+3.1%)
|
13.19M
est: 14.24M (-7.3%)
|
11.08M
est: 16.02M (-30.8%)
|
9.34M
9.34M – 9.34M
-41.7% YoY
|
273.63M
273.63M – 273.63M
+2,828.6% YoY
|
363.05M
363.05M – 363.05M
+32.7% YoY
|
1.33B
1.33B – 1.33B
+267.6% YoY
|
| EPS |
-101.65
est: -153.36 (+33.7%)
|
-170.94
est: -175.97 (+2.9%)
|
-141.90
est: -55.04 (-157.8%)
|
-25.65
est: -24.03 (-6.7%)
|
-10.65
est: -8.52 (-25.0%)
|
-2.77
est: -0.94 (-196.0%)
|
-0.94
est: -0.96 (+2.1%)
|
-0.62
est: -0.86 (+27.6%)
|
-0.59
-0.59 – -0.59
+31.1% YoY
|
-0.64
-0.64 – -0.64
-8.5% YoY
|
-0.64
-0.64 – -0.64
+0.0% YoY
|
-2.65
-2.65 – -2.65
-314.1% YoY
|
Historical Ratings (3M)
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-15 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-14 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-13 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-12 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-11 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-08 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-07 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-06 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-05 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-04 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-05-01 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-30 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-29 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-28 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-27 | C | 2/5 | 3/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-24 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-23 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-22 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-21 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-20 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-17 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
| 2026-04-16 | C+ | 2/5 | 4/5 | 1/5 | 1/5 | 1/5 | 1/5 | 4/5 |
Owner Earnings
Owner's Earnings (history)
From
To
Owner alignment
Owner's Earnings TTM
-25.77M
OE per share TTM
-0.60
Owner's Yield
-89.92%
Maintenance CapEx ratio
—
Maint CapEx / Avg PPE
15.5%
Ownership Overview
Ownership breakdown
At a glance
Institutional holders
13
Total invested
1.95M
Insider transactions (90d)
0
Beneficial owners (>5%)
40
Beneficial owners (>5%)
| # | Reporting person | Amount owned | % of class | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Type | Citizenship | Filing date | SEC filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | (1)Names of reporting persons. BlackRock, Inc. | 11.99M | 7.10% | 11.85M | — | 11.99M | — | HC | Delaware | 2021-02-02 | ↗ |
| 2 | Vivo Capital VIII, LLC | 4.01M | 17.50% | 4.01M | — | 4.01M | — | OO | Delaware | 2018-02-02 | ↗ |
| 3 | AI Biotechnology LLC | 3.20M | 19.99% | — | 3.20M | — | 3.20M | OO | — | 2023-11-13 | ↗ |
| 4 | Access Industries Holdings LLC | 3.20M | 19.99% | — | 3.20M | — | 3.20M | OO | — | 2023-11-13 | ↗ |
| 5 | Access Industries Management, LLC | 3.20M | 19.99% | — | 3.20M | — | 3.20M | OO | — | 2023-11-13 | ↗ |
| 6 | Len Blavatnik | 3.20M | 19.99% | — | 3.20M | — | 3.20M | IN | — | 2023-11-13 | ↗ |
| 7 | First Trust Portfolios L.P., First Trust Advisors L.P., The Charger Corporation | 2.66M | 5.03% | — | 2.32M | — | 2.32M | BD, IA, HC | Jersey, Channel Islands | 2018-05-10 | ↗ |
| 8 | Joseph Edelman | 2.43M | 4.50% | — | 2.43M | — | 2.43M | IN | Delaware | 2022-02-15 | ↗ |
| 9 | Perceptive Advisors LLC | 2.43M | 4.50% | — | 2.43M | — | 2.43M | IA | Delaware | 2022-02-15 | ↗ |
| 10 | Perceptive Life Sciences Master Fund, Ltd. | 2.43M | 4.50% | — | 2.43M | — | 2.43M | CO | Delaware | 2022-02-15 | ↗ |
| 11 | Mr. David Kroin | 1.56M | 6.77% | — | 1.56M | — | 1.56M | IN | USA | 2018-08-13 | ↗ |
| 12 | Steven A. Cohen | 1.40M | 4.00% | — | 1.40M | — | 1.40M | IN | Delaware | 2020-01-21 | ↗ |
| 13 | Point72 Asset Management, L.P. | 1.40M | 4.00% | — | 1.40M | — | 1.40M | PN | Delaware | 2020-01-21 | ↗ |
| 14 | Point72 Capital Advisors, Inc. | 1.40M | 4.00% | — | 1.40M | — | 1.40M | CO | Delaware | 2020-01-21 | ↗ |
| 15 | Bihua Chen | 1.39M | 9.99% | — | 1.39M | — | 1.39M | IN | Cayman Islands | 2023-11-13 | ↗ |
| 16 | Cormorant Asset Management, LP | 1.39M | 9.99% | — | 1.39M | — | 1.39M | PN | Cayman Islands | 2023-11-13 | ↗ |
| 17 | Cormorant Global Healthcare GP, LLC | 1.39M | 9.99% | — | 1.39M | — | 1.39M | OO | Cayman Islands | 2023-11-13 | ↗ |
| 18 | Cormorant Global Healthcare Master Fund, LP | 1.39M | 9.99% | — | 1.39M | — | 1.39M | PN | Cayman Islands | 2023-11-13 | ↗ |
| 19 | Eventide Asset Management, LLC | 1.39M | 9.99% | 1.39M | — | 1.39M | — | IA | Delaware | 2023-11-13 | ↗ |
| 20 | Finny Kuruvilla, M.D. Ph. D. | 1.39M | 9.99% | — | 1.39M | — | — | HC, IN | United States | 2023-11-13 | ↗ |
| 21 | Robin C. John | 1.39M | 9.99% | — | 1.39M | — | — | HC, IN | United States | 2023-11-13 | ↗ |
| 22 | Merck & Co., Inc. | 1.24M | 5.41% | 1.24M | — | 1.24M | — | HC | New Jersey | 2018-02-14 | ↗ |
| 23 | Merck Foundation, a New Jersey Nonprofit Corporation | 1.24M | 5.41% | 1.24M | — | 1.24M | — | CO | New Jersey | 2019-02-14 | ↗ |
| 24 | Merck Sharp & Dohme Corp. | 1.24M | 5.41% | 1.24M | — | 1.24M | — | CO | New Jersey | 2018-02-14 | ↗ |
| 25 | Novo Holdings A/S | 1.16M | 5.05% | 1.16M | — | 1.16M | — | CO | Denmark | 2018-02-08 | ↗ |
| 26 | Abigail P. Johnson | 1.12M | 5.10% | — | — | 1.12M | — | IN | Delaware | 2018-01-31 | ↗ |
| 27 | FMR LLC | 1.12M | 5.10% | 1.09M | — | 1.12M | — | HC | Delaware | 2018-01-31 | ↗ |
| 28 | (1) BlackRock, Inc. | 1.04M | 2.00% | 1.04M | — | 1.04M | — | HC | Delaware | 2021-07-12 | ↗ |
| 29 | Guy Levy | 890.9K | 6.40% | — | 890.9K | — | 890.9K | IN | OR PLACE OF ORGANIZATION | 2023-11-02 | ↗ |
| 30 | Soleus Capital Master Fund, L.P. | 890.9K | 6.40% | — | 890.9K | — | 890.9K | FI | OR PLACE OF ORGANIZATION | 2023-11-02 | ↗ |
| 31 | Soleus Capital Group, LLC | 890.9K | 6.40% | — | 890.9K | — | 890.9K | OO | OR PLACE OF ORGANIZATION | 2023-11-02 | ↗ |
| 32 | Soleus Capital, LLC | 890.9K | 6.40% | — | 890.9K | — | 890.9K | OO | OR PLACE OF ORGANIZATION | 2023-11-02 | ↗ |
| 33 | First Manhattan Co. | 21.3K | 0.01% | — | 21.3K | — | — | BD, IA | New York | 2021-02-16 | ↗ |
| 34 | Cubist Systematic Strategies, LLC | 600.00 | 4.00% | — | 600.00 | — | 600.00 | OO | Delaware | 2020-01-21 | ↗ |
| 35 | Point72 Hong Kong Limited | 125.00 | 4.00% | — | 125.00 | — | 125.00 | OO | Delaware | 2020-01-21 | ↗ |
| 36 | 2. | 10.00 | 8.50% | — | 1.18M | — | — | IA, HC, OO | Delaware | 2023-11-13 | ↗ |
| 37 | Dr. Jeffrey R. Jay, M.D. | — | 0.00% | — | — | — | — | HC, IN | USA | 2021-02-16 | ↗ |
| 38 | EIN #00-0000000 | — | 0.00% | — | — | — | — | IA, HC | Jersey Channel Islands | 2021-02-11 | ↗ |
| 39 | Great Point Partners, LLC | — | 0.00% | — | — | — | — | IA, OO | USA | 2021-02-16 | ↗ |
| 40 | Mr. Ortav Yehudai | — | 0.00% | — | — | — | — | HC, IN | USA | 2021-02-16 | ↗ |
Institutional Activity (13F)
Institutional ownership trend
From
To
13F snapshot — 2026 Q1
Investors holding
13
-26 vs prev Q
New positions
4
Closed positions
30
Increased
6
Reduced
0
Put/Call ratio
0.00
Calls held
—
Puts held
—
Top institutional holders
| # | Investor | Shares / Δ | Mkt value / Δ | Own% / Δ | Weight% / Δ | Avg px / Perf. | Hold / Status |
|---|---|---|---|---|---|---|---|
| 1 | — | 500.6K +500.6K (+100.0%) | 290.37M +290.4M (+100.0%) | 1.17% +1.171 pp | 0.28% +0.281 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 2 | SHAY CAPITAL LLC | 1.62M +1.1M (+229.8%) | 942.3K +777.3K (+471.0%) | 3.80% +2.648 pp | 0.10% +0.083 pp | USD0.51 +13.7% | 4 qtrs — |
| 3 | ANSON FUNDS MANAGEMENT LP | 1.27M +1.3M (+100.0%) | 739.3K +739.3K (+100.0%) | 2.98% +2.981 pp | 0.07% +0.070 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 4 | NANTAHALA CAPITAL MANAGEMENT, LLC | 1.00M +1.0M (+100.0%) | 580.1K +580.1K (+100.0%) | 2.34% +2.340 pp | 0.02% +0.019 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 5 | ACADIAN ASSET MANAGEMENT LLC | 638.5K +192.1K (+43.0%) | 370.0K +222.0K (+150.0%) | 1.49% +0.450 pp | 0.00% +0.000 pp | USD0.45 +28.9% | 3 qtrs — |
| 6 | VANGUARD GROUP INC | 314.5K +124.2K (+65.2%) | 182.4K +118.7K (+186.0%) | 0.74% +0.291 pp | 0.00% +0.000 pp | USD1.54 -62.3% | 12 qtrs — |
| 7 | IKARIAN CAPITAL, LLC | 264.9K -25.1K (-8.7%) | 153.7K +56.5K (+58.2%) | 0.62% -0.059 pp | 0.01% +0.002 pp | USD1.65 -64.8% | 3 qtrs — |
| 8 | ADAR1 CAPITAL MANAGEMENT, LLC | 253.8K +253.8K (+100.0%) | 147.2K +147.2K (+100.0%) | 0.59% +0.594 pp | 0.01% +0.011 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 9 | GEODE CAPITAL MANAGEMENT, LLC | 225.2K +88.0K (+64.2%) | 130.6K +84.7K (+184.3%) | 0.53% +0.206 pp | 0.00% +0.000 pp | USD1.70 -65.9% | 12 qtrs — |
| 10 | TWO SIGMA INVESTMENTS, LP | 220.0K -788.0 (-0.4%) | 127.6K +53.7K (+72.5%) | 0.51% -0.002 pp | 0.00% +0.000 pp | USD0.34 +70.6% | 2 qtrs — |
| 11 | TWO SIGMA ADVISERS, LP | 163.1K +106.5K (+188.2%) | 94.6K +75.7K (+399.0%) | 0.38% +0.249 pp | 0.00% +0.000 pp | USD0.50 +16.0% | 2 qtrs — |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 100.3K +42.6K (+73.7%) | 58.2K +38.9K (+200.8%) | 0.23% +0.100 pp | 0.00% +0.000 pp | USD2.42 -76.0% | 12 qtrs — |
| 13 | RANGELEY CAPITAL, LLC | 100.0K +50.0K (+100.0%) | 58.0K +41.3K (+246.3%) | 0.23% +0.117 pp | 0.05% +0.034 pp | USD0.46 +26.1% | 2 qtrs — |
| 14 | BOOTHBAY FUND MANAGEMENT, LLC | 81.4K -25.1K (-23.6%) | 47.2K +11.5K (+32.4%) | 0.19% -0.059 pp | 0.00% +0.000 pp | USD1.65 -64.8% | 3 qtrs — |
| 15 | XTX TOPCO LTD | 79.0K +79.0K (+100.0%) | 45.9K +45.9K (+100.0%) | 0.18% +0.185 pp | 0.00% +0.001 pp | USD0.58 +0.0% | 5 qtrs — |
| 16 | JANE STREET GROUP, LLC | 72.4K -74.8K (-50.8%) | 42.0K -7.3K (-14.8%) | 0.17% -0.175 pp | 0.00% +0.000 pp | USD1.45 -60.0% | 5 qtrs — |
| 17 | UBS GROUP AG | 62.8K +57.2K (+1,026.4%) | 36.4K +34.5K (+1,850.8%) | 0.15% +0.134 pp | 0.00% +0.000 pp | USD0.56 +3.6% | 12 qtrs — |
| 18 | GSA CAPITAL PARTNERS LLP | 54.0K +18.0K (+50.2%) | 31.0K +19.0K (+158.3%) | 0.13% +0.042 pp | 0.00% +0.002 pp | USD0.75 -22.7% | 3 qtrs — |
| 19 | BLACKROCK, INC. | 44.4K +— (+0.0%) | 25.8K +10.9K (+73.2%) | 0.10% +0.000 pp | 0.00% +0.000 pp | USD1.88 -69.1% | 6 qtrs — |
| 20 | CITADEL ADVISORS LLC | 30.5K +30.5K (+100.0%) | 17.7K +17.7K (+100.0%) | 0.07% +0.071 pp | 0.00% +0.000 pp | USD0.58 +0.0% | 9 qtrs — |
| 21 | VIRTU FINANCIAL LLC | 25.3K +25.3K (+100.0%) | 15.0K +15.0K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.001 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 22 | FNY INVESTMENT ADVISERS, LLC | 25.0K +25.0K (+100.0%) | 14.0K +14.0K (+100.0%) | 0.06% +0.059 pp | 0.00% +0.004 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 23 | NORTHERN TRUST CORP | 23.1K +— (+0.0%) | 13.4K +5.7K (+73.2%) | 0.05% +0.000 pp | 0.00% +0.000 pp | USD2.32 -75.0% | 9 qtrs — |
| 24 | COMMONWEALTH EQUITY SERVICES, LLC | 18.3K +— (+0.0%) | 10.6K +4.6K (+76.8%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD1.88 -69.1% | 6 qtrs — |
| 25 | STATE STREET CORP | 15.8K +— (+0.0%) | 9.1K +3.9K (+73.2%) | 0.04% +0.000 pp | 0.00% +0.000 pp | USD2.78 -79.1% | 12 qtrs — |
| 26 | HARVEST INVESTMENT SERVICES, LLC | 11.1K +— (+0.0%) | 6.4K +2.7K (+73.1%) | 0.03% +0.000 pp | 0.00% +0.001 pp | USD1.65 -64.8% | 3 qtrs — |
| 27 | TOWER RESEARCH CAPITAL LLC (TRC) | 3.6K -30.0 (-0.8%) | 2.1K +864.0 (+71.7%) | 0.01% 0.000 pp | 0.00% +0.000 pp | USD1.49 -61.1% | 10 qtrs — |
| 28 | ROYAL BANK OF CANADA | 2.4K +1.0 (+0.0%) | 1.0K +— (+0.0%) | 0.01% +0.000 pp | 0.00% +0.000 pp | USD3.32 -82.5% | 12 qtrs — |
| 29 | BANK OF AMERICA CORP /DE/ | 1.7K +145.0 (+9.5%) | 973.00 +460.0 (+89.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.56 -62.8% | 12 qtrs — |
| 30 | ACORN CAPITAL ADVISORS, LLC | 1.4K -585.1K (-99.8%) | 827.00 -198.6K (-99.6%) | 0.00% -1.369 pp | 0.00% -0.101 pp | USD2.61 -77.8% | 5 qtrs — |
| 31 | MB, LEVIS & ASSOCIATES, LLC | 1.0K +— (+0.0%) | 604.00 +255.0 (+73.1%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD3.08 -81.2% | 12 qtrs — |
| 32 | NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | 800.00 +800.0 (+100.0%) | 464.00 +464.0 (+100.0%) | 0.00% +0.002 pp | 0.00% +0.000 pp | USD0.58 +0.0% | 3 qtrs — |
| 33 | HURLEY CAPITAL, LLC | 561.00 +561.0 (+100.0%) | 325.00 +325.0 (+100.0%) | 0.00% +0.001 pp | 0.00% +0.000 pp | USD0.58 +0.0% | 1 qtrs NEW |
| 34 | JPMORGAN CHASE & CO | 146.00 +— (+0.0%) | 85.00 +36.0 (+73.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.68 -65.5% | 11 qtrs — |
| 35 | WELLS FARGO & COMPANY/MN | 65.00 +— (+0.0%) | 38.00 +16.0 (+72.7%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD2.88 -79.9% | 12 qtrs — |
| 36 | MORGAN STANLEY | 43.00 -868.0 (-95.3%) | 25.00 -280.0 (-91.8%) | 0.00% -0.002 pp | 0.00% +0.000 pp | USD2.19 -73.5% | 12 qtrs — |
| 37 | TRUVESTMENTS CAPITAL LLC | 25.00 +— (+0.0%) | 15.00 +7.0 (+87.5%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD1.56 -62.8% | 4 qtrs — |
| 38 | NEWBRIDGE FINANCIAL SERVICES GROUP, INC. | 10.00 +— (+0.0%) | 6.00 +3.0 (+100.0%) | 0.00% +0.000 pp | 0.00% +0.000 pp | USD0.30 +93.3% | 2 qtrs — |
| 39 | CORSAIR CAPITAL MANAGEMENT, L.P. | — -50.0K (-100.0%) | — -16.8K (-100.0%) | 0.00% -0.117 pp | 0.00% -0.003 pp | USD— | 3 qtrs SOLD |
| 40 | BARCLAYS PLC | — -100.0 (-100.0%) | — -188.0 (-100.0%) | 0.00% 0.000 pp | 0.00% +0.000 pp | USD— | 2 qtrs SOLD |
| 41 | BAKER BROS. ADVISORS LP | — -851.4K (-100.0%) | — -285.2K (-100.0%) | 0.00% -1.991 pp | 0.00% -0.002 pp | USD— | 2 qtrs SOLD |
| 42 | BRIDGEWAY CAPITAL MANAGEMENT, LLC | — -77.0K (-100.0%) | — -25.8K (-100.0%) | 0.00% -0.180 pp | 0.00% -0.001 pp | USD— | 5 qtrs SOLD |
Ownership breakdown by holder
ETF Ownership
Top ETFs holding this stock
Held by 1 ETFs in our universe
| # | ETF | Weight | Est. AUM exposure | TER |
|---|---|---|---|---|
| 1 | Vanguard Extended Market ETF VXF | 0.00% | 176.3K | 0.05% |
Insider Activity
Insider Activity — Latest Quarter
Ratio by transactions
0.00
Bearish
Ratio by volume
0.00
Bearish
Buys
0
Sells
4
Shares acquired
—
Shares disposed
25.1K
Cash buys
—
Cash sales
—
Net activity
-25,122
Insider buys vs sells (history)
From
To
Recent insider transactions
From
To
| Date | Person | Role | Transaction | A/D | Security | Shares | Price | Value | Owned after | D/I | Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 4,007 | 0.60 | 2.4K | 99,788 | D | ↗ |
| 2026-03-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,876 | 0.60 | 1.7K | 112,363 | D | ↗ |
| 2026-03-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 4,007 | 0.60 | 2.4K | 121,898 | D | ↗ |
| 2026-03-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 14,232 | 0.60 | 8.5K | 401,976 | D | ↗ |
| 2025-12-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 7,858 | 0.58 | 4.6K | 103,795 | D | ↗ |
| 2025-12-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,448 | 0.58 | 1.4K | 115,239 | D | ↗ |
| 2025-12-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 3,579 | 0.58 | 2.1K | 125,905 | D | ↗ |
| 2025-12-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 12,684 | 0.58 | 7.4K | 416,208 | D | ↗ |
| 2025-12-12 | Little Elisabeth Sandoval | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.38 | 7.5K | 20,000 | D | ↗ |
| 2025-12-12 | LEPORE PATRICK G | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.38 | 7.5K | 20,000 | D | ↗ |
| 2025-12-12 | Basta Steven L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.38 | 7.5K | 20,000 | D | ↗ |
| 2025-12-12 | BARBARI SHARON | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 0.38 | 7.5K | 20,000 | D | ↗ |
| 2025-09-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 3,420 | 0.34 | 1.1K | 111,653 | D | ↗ |
| 2025-09-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,453 | 0.34 | 821.76 | 117,687 | D | ↗ |
| 2025-09-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 3,581 | 0.34 | 1.2K | 129,484 | D | ↗ |
| 2025-09-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 12,676 | 0.34 | 4.2K | 428,892 | D | ↗ |
| 2025-06-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 3,420 | 1.65 | 5.6K | 115,073 | D | ↗ |
| 2025-06-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,453 | 1.65 | 4.0K | 120,140 | D | ↗ |
| 2025-06-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 3,581 | 1.65 | 5.9K | 133,065 | D | ↗ |
| 2025-06-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 12,676 | 1.65 | 20.9K | 441,568 | D | ↗ |
| 2025-06-02 | Harsch Mutya | Officer | A-Award | A | Common Stock | 1,145 | 0.81 | 927.45 | 136,646 | D | ↗ |
| 2025-06-02 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 8,681 | 0.81 | 7.0K | 454,244 | D | ↗ |
| 2025-03-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 8,399 | 1.58 | 13.3K | 118,493 | D | ↗ |
| 2025-03-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 6,044 | 1.58 | 9.5K | 122,593 | D | ↗ |
| 2025-03-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 8,828 | 1.58 | 13.9K | 135,501 | D | ↗ |
| 2025-03-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 30,498 | 1.58 | 48.2K | 445,563 | D | ↗ |
| 2025-01-21 | Zeronda Tyler | Officer | A-Award | A | Stock Option (right to buy) | 230,000 | 2.77 | 637.1K | 230,000 | D | ↗ |
| 2025-01-21 | Stuart Iain | Officer | A-Award | A | Stock Option (right to buy) | 230,000 | 2.77 | 637.1K | 230,000 | D | ↗ |
| 2025-01-21 | Harsch Mutya | Officer | A-Award | A | Stock Option (right to buy) | 230,000 | 2.77 | 637.1K | 230,000 | D | ↗ |
| 2025-01-21 | Domzalski David | Director / Officer | A-Award | A | Stock Option (right to buy) | 730,000 | 2.77 | 2.02M | 730,000 | D | ↗ |
| 2025-01-15 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 15,000 | 2.92 | 43.8K | 51,472 | D | ↗ |
| 2024-12-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 4,675 | 3.35 | 15.7K | 126,892 | D | ↗ |
| 2024-12-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 4,857 | 3.35 | 16.3K | 128,637 | D | ↗ |
| 2024-12-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 4,697 | 3.35 | 15.7K | 144,329 | D | ↗ |
| 2024-12-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 24,536 | 3.35 | 82.2K | 476,061 | D | ↗ |
| 2024-12-12 | Sandoval Elisabeth | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.40 | 48.0K | 20,000 | D | ↗ |
| 2024-12-12 | LEPORE PATRICK G | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.40 | 48.0K | 20,000 | D | ↗ |
| 2024-12-12 | Bruno Anthony D | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.40 | 48.0K | 20,000 | D | ↗ |
| 2024-12-12 | Borowski Christine | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.40 | 48.0K | 20,000 | D | ↗ |
| 2024-12-12 | Basta Steven L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.40 | 48.0K | 20,000 | D | ↗ |
| 2024-12-12 | BARBARI SHARON | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.40 | 48.0K | 20,000 | D | ↗ |
| 2024-11-30 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 3,901 | 2.10 | 8.2K | 500,597 | D | ↗ |
| 2024-09-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 84 | 1.88 | 157.92 | 131,567 | D | ↗ |
| 2024-09-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 109 | 1.88 | 204.92 | 133,494 | D | ↗ |
| 2024-09-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 105 | 1.88 | 197.40 | 149,026 | D | ↗ |
| 2024-09-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 685 | 1.88 | 1.3K | 496,696 | D | ↗ |
| 2024-07-01 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 92 | 1.92 | 176.64 | 131,651 | — | ↗ |
| 2024-07-01 | Stuart Iain | Officer | F-InKind | D | Common Stock | 138 | 1.92 | 264.96 | 133,603 | — | ↗ |
| 2024-07-01 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 143 | 1.92 | 274.56 | 149,131 | — | ↗ |
| 2024-07-01 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 935 | 1.92 | 1.8K | 497,654 | — | ↗ |
| 2024-05-31 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 4,429 | 2.16 | 9.6K | 498,589 | — | ↗ |
| 2024-04-01 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 94 | 3.08 | 289.52 | 131,743 | — | ↗ |
| 2024-04-01 | Stuart Iain | Officer | F-InKind | D | Common Stock | 157 | 3.08 | 483.56 | 133,741 | — | ↗ |
| 2024-04-01 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 161 | 3.08 | 495.88 | 149,274 | — | ↗ |
| 2024-04-01 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 1,004 | 3.08 | 3.1K | 494,160 | — | ↗ |
| 2024-01-02 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 93 | 2.28 | 212.04 | 131,837 | — | ↗ |
| 2024-01-02 | Stuart Iain | Officer | F-InKind | D | Common Stock | 157 | 2.28 | 357.96 | 133,898 | — | ↗ |
| 2024-01-02 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 161 | 2.28 | 367.08 | 149,435 | — | ↗ |
| 2024-01-02 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 1,004 | 2.28 | 2.3K | 495,164 | — | ↗ |
| 2024-01-01 | Zeronda Tyler | Officer | A-Award | A | Stock Option (right to buy) | 62,500 | 2.33 | 145.6K | 62,500 | — | ↗ |
| 2024-01-01 | Stuart Iain | Officer | A-Award | A | Common Stock | 62,500 | 0.00 | — | 134,055 | — | ↗ |
| 2024-01-01 | Sandoval Elisabeth | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.33 | 46.6K | 20,000 | — | ↗ |
| 2024-01-01 | LEPORE PATRICK G | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.33 | 46.6K | 20,000 | — | ↗ |
| 2024-01-01 | Harsch Mutya | Officer | A-Award | A | Stock Option (right to buy) | 62,500 | 2.33 | 145.6K | 62,500 | — | ↗ |
| 2024-01-01 | Domzalski David | Director / Officer | A-Award | A | Stock Option (right to buy) | 225,000 | 2.33 | 524.3K | 225,000 | — | ↗ |
| 2024-01-01 | Bruno Anthony D | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.33 | 46.6K | 20,000 | — | ↗ |
| 2024-01-01 | Borowski Christine | Director | A-Award | A | Stock Option (right to buy) | 40,000 | 2.33 | 93.2K | 40,000 | — | ↗ |
| 2024-01-01 | Basta Steven L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.33 | 46.6K | 20,000 | — | ↗ |
| 2024-01-01 | BARBARI SHARON | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.33 | 46.6K | 20,000 | — | ↗ |
| 2023-12-29 | Borowski Christine | Director | — | — | — | 0 | 0.00 | — | 0 | — | ↗ |
| 2023-12-13 | Zeronda Tyler | Officer | A-Award | A | Stock Option (right to buy) | 62,500 | 2.70 | 168.8K | 62,500 | — | ↗ |
| 2023-12-13 | Stuart Iain | Officer | A-Award | A | Stock Option (right to buy) | 62,500 | 2.70 | 168.8K | 62,500 | — | ↗ |
| 2023-12-13 | Sandoval Elisabeth | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.70 | 54.0K | 20,000 | — | ↗ |
| 2023-12-13 | LEPORE PATRICK G | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.70 | 54.0K | 20,000 | — | ↗ |
| 2023-12-13 | Harsch Mutya | Officer | A-Award | A | Stock Option (right to buy) | 62,500 | 2.70 | 168.8K | 62,500 | — | ↗ |
| 2023-12-13 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 225,000 | 0.00 | — | 271,168 | — | ↗ |
| 2023-12-13 | Bruno Anthony D | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.70 | 54.0K | 20,000 | — | ↗ |
| 2023-12-13 | Basta Steven L | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.70 | 54.0K | 20,000 | — | ↗ |
| 2023-12-13 | BARBARI SHARON | Director | A-Award | A | Stock Option (right to buy) | 20,000 | 2.70 | 54.0K | 20,000 | — | ↗ |
| 2023-11-30 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 2,284 | 2.81 | 6.4K | 46,168 | — | ↗ |
| 2023-11-15 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 13,000 | 3.91 | 50.8K | 36,472 | — | ↗ |
| 2023-11-01 | AI Biotechnology LLC | 10% Owner | — | D | Common Stock | 0 | 0.00 | — | 1,116,585 | — | ↗ |
| 2023-10-02 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 1,087 | 3.83 | 4.2K | 6,930 | — | ↗ |
| 2023-10-02 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,184 | 3.83 | 4.5K | 9,055 | — | ↗ |
| 2023-10-02 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,154 | 3.83 | 4.4K | 24,596 | — | ↗ |
| 2023-10-02 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 8,549 | 3.83 | 32.7K | 43,884 | — | ↗ |
| 2023-06-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 91 | 4.10 | 373.10 | 8,017 | — | ↗ |
| 2023-06-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 151 | 4.10 | 619.10 | 10,239 | — | ↗ |
| 2023-06-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 157 | 4.10 | 643.70 | 25,750 | — | ↗ |
| 2023-06-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 981 | 4.10 | 4.0K | 52,433 | — | ↗ |
| 2023-05-31 | Harsch Mutya | Officer | A-Award | A | Common Stock | 3,664 | 3.46 | 12.7K | 25,907 | — | ↗ |
| 2023-05-31 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 2,766 | 3.46 | 9.6K | 53,414 | — | ↗ |
| 2023-03-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 384 | 3.08 | 1.2K | 8,108 | — | ↗ |
| 2023-03-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 480 | 3.08 | 1.5K | 10,390 | — | ↗ |
| 2023-03-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 478 | 3.08 | 1.5K | 22,243 | — | ↗ |
| 2023-03-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 2,734 | 3.08 | 8.4K | 50,648 | — | ↗ |
| 2023-03-20 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 20,000 | 2.48 | 49.7K | 23,472 | — | ↗ |
| 2023-03-20 | Harsch Mutya | Officer | P-Purchase | A | Common Stock | 10,000 | 2.50 | 25.0K | 22,721 | — | ↗ |
| 2022-12-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 354 | 0.15 | 53.10 | 173,005 | — | ↗ |
| 2022-12-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,720 | 0.15 | 258.00 | 220,252 | — | ↗ |
| 2022-12-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,813 | 0.15 | 271.95 | 229,144 | — | ↗ |
| 2022-12-31 | Domzalski David | Officer | F-InKind | D | Common Stock | 10,685 | 0.15 | 1.6K | 1,064,290 | — | ↗ |
| 2022-11-30 | Domzalski David | Officer | A-Award | A | Common Stock | 34,705 | 0.20 | 6.9K | 1,074,975 | — | ↗ |
| 2022-09-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 353 | 0.22 | 78.72 | 173,359 | — | ↗ |
| 2022-09-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,719 | 0.22 | 383.34 | 221,972 | — | ↗ |
| 2022-09-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,813 | 0.22 | 404.30 | 230,957 | — | ↗ |
| 2022-09-30 | Domzalski David | Officer | F-InKind | D | Common Stock | 10,683 | 0.22 | 2.4K | 1,040,270 | — | ↗ |
| 2022-08-10 | Sandoval Elisabeth | Director | A-Award | A | Stock Options | 20,500 | 0.31 | 6.4K | 20,500 | — | ↗ |
| 2022-08-10 | LEPORE PATRICK G | Director | A-Award | A | Stock Options | 20,500 | 0.31 | 6.4K | 20,500 | — | ↗ |
| 2022-08-10 | Bruno Anthony D | Director | A-Award | A | Stock Options | 20,500 | 0.00 | — | 20,500 | — | ↗ |
| 2022-08-10 | Basta Steven L | Director | A-Award | A | Stock Options | 20,500 | 0.00 | — | 20,500 | — | ↗ |
| 2022-08-10 | BARBARI SHARON | Director | A-Award | A | Stock Options | 20,500 | 0.31 | 6.4K | 20,500 | — | ↗ |
| 2022-06-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 354 | 0.39 | 137.71 | 173,712 | — | ↗ |
| 2022-06-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,719 | 0.39 | 668.69 | 223,691 | — | ↗ |
| 2022-06-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,813 | 0.39 | 705.26 | 232,770 | — | ↗ |
| 2022-06-30 | Domzalski David | Officer | F-InKind | D | Common Stock | 10,683 | 0.39 | 4.2K | 1,050,953 | — | ↗ |
| 2022-05-31 | Zeronda Tyler | Officer | A-Award | A | Common Stock | 12,510 | 0.35 | 4.3K | 174,066 | — | ↗ |
| 2022-05-31 | Domzalski David | Officer | A-Award | A | Common Stock | 11,887 | 0.35 | 4.1K | 1,061,636 | — | ↗ |
| 2022-03-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 773 | 0.65 | 502.45 | 161,556 | — | ↗ |
| 2022-03-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 3,469 | 0.65 | 2.3K | 225,410 | — | ↗ |
| 2022-03-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 3,630 | 0.65 | 2.4K | 234,583 | — | ↗ |
| 2022-03-31 | Domzalski David | Officer | F-InKind | D | Common Stock | 23,186 | 0.65 | 15.1K | 1,049,749 | — | ↗ |
| 2022-03-17 | Zeronda Tyler | Officer | A-Award | A | Stock Options | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2022-03-17 | Stuart Iain | Officer | A-Award | A | Stock Options | 75,000 | 0.00 | — | 75,000 | — | ↗ |
| 2022-03-17 | Harsch Mutya | Officer | A-Award | A | Common Stock | 75,000 | 0.00 | — | 238,213 | — | ↗ |
| 2022-03-17 | Domzalski David | Director / Officer | A-Award | A | Stock Options | 312,303 | 0.61 | 190.5K | 312,303 | — | ↗ |
| 2021-12-31 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 206 | 1.02 | 210.12 | 87,329 | — | ↗ |
| 2021-12-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,250 | 1.02 | 1.3K | 153,879 | — | ↗ |
| 2021-12-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,484 | 1.02 | 1.5K | 163,213 | — | ↗ |
| 2021-12-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 6,887 | 1.02 | 7.0K | 760,633 | — | ↗ |
| 2021-11-30 | Zeronda Tyler | Officer | A-Award | A | Common Stock | 4,187 | 0.88 | 3.7K | 87,535 | — | ↗ |
| 2021-11-30 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 12,500 | 1.02 | 12.7K | 62,500 | — | ↗ |
| 2021-11-30 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 4,705 | 0.88 | 4.1K | 767,520 | — | ↗ |
| 2021-09-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 206 | 1.39 | 286.34 | 83,348 | — | ↗ |
| 2021-09-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,480 | 1.39 | 2.1K | 155,129 | — | ↗ |
| 2021-09-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,484 | 1.39 | 2.1K | 164,697 | — | ↗ |
| 2021-09-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 13,096 | 1.39 | 18.2K | 762,815 | — | ↗ |
| 2021-09-02 | Zeronda Tyler | Officer | A-Award | A | Common Stock | 60,859 | 0.00 | — | 83,554 | — | ↗ |
| 2021-09-02 | Stuart Iain | Officer | A-Award | A | Common Stock | 60,859 | 0.00 | — | 156,609 | — | ↗ |
| 2021-09-02 | Harsch Mutya | Officer | A-Award | A | Common Stock | 60,859 | 0.00 | — | 166,181 | — | ↗ |
| 2021-09-02 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 320,312 | 0.00 | — | 775,911 | — | ↗ |
| 2021-08-25 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 12,500 | 1.60 | 20.0K | 50,000 | — | ↗ |
| 2021-08-16 | PERCEPTIVE ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 250,000 | 1.74 | 435.0K | 4,935,057 | — | ↗ |
| 2021-08-13 | PERCEPTIVE ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 250,000 | 1.84 | 460.0K | 5,185,057 | — | ↗ |
| 2021-08-12 | PERCEPTIVE ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 338,897 | 2.23 | 755.7K | 5,435,057 | — | ↗ |
| 2021-07-19 | Sandoval Elisabeth | Director | A-Award | A | Stock Options | 20,500 | 2.75 | 56.4K | 20,500 | — | ↗ |
| 2021-07-19 | LEPORE PATRICK G | Director | A-Award | A | Stock Options | 20,500 | 2.75 | 56.4K | 20,500 | — | ↗ |
| 2021-07-19 | Bruno Anthony D | Director | A-Award | A | Stock Options | 20,500 | 2.75 | 56.4K | 20,500 | — | ↗ |
| 2021-07-19 | Bright Rex | Director | A-Award | A | Stock Options | 20,500 | 2.75 | 56.4K | 20,500 | — | ↗ |
| 2021-07-19 | Basta Steven L | Director | A-Award | A | Stock Options | 20,500 | 2.75 | 56.4K | 20,500 | — | ↗ |
| 2021-07-19 | BARBARI SHARON | Director | A-Award | A | Stock Options | 20,500 | 2.75 | 56.4K | 20,500 | — | ↗ |
| 2021-06-30 | Zeronda Tyler | Officer | F-InKind | D | Common Stock | 700 | 3.51 | 2.5K | 22,695 | — | ↗ |
| 2021-06-30 | Wiley Matthew T. | Officer | F-InKind | D | Common Stock | 5,151 | 3.51 | 18.1K | 109,246 | — | ↗ |
| 2021-06-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 3,083 | 3.51 | 10.8K | 95,750 | — | ↗ |
| 2021-06-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 3,551 | 3.51 | 12.5K | 105,322 | — | ↗ |
| 2021-06-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 18,859 | 3.51 | 66.2K | 455,599 | — | ↗ |
| 2021-06-18 | Zeronda Tyler | Officer | — | D | Common Stock | 0 | 0.00 | — | 23,395 | — | ↗ |
| 2021-05-28 | Saik Andrew | Officer | A-Award | A | Common Stock | 3,017 | 3.36 | 10.1K | 116,468 | — | ↗ |
| 2021-05-28 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 941 | 3.36 | 3.2K | 474,458 | — | ↗ |
| 2021-05-26 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 12,500 | 3.60 | 45.0K | 37,500 | — | ↗ |
| 2021-05-06 | PERCEPTIVE ADVISORS LLC | 10% Owner | S-Sale | D | Common Stock | 1,000,000 | 3.67 | 3.67M | 5,773,954 | — | ↗ |
| 2021-03-31 | Wiley Matthew T. | Officer | F-InKind | D | Common Stock | 2,573 | 6.84 | 17.6K | 114,397 | — | ↗ |
| 2021-03-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 1,945 | 6.84 | 13.3K | 98,833 | — | ↗ |
| 2021-03-31 | Saik Andrew | Officer | F-InKind | D | Common Stock | 762 | 6.84 | 5.2K | 113,451 | — | ↗ |
| 2021-03-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,765 | 6.84 | 12.1K | 108,873 | — | ↗ |
| 2021-03-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 6,316 | 6.84 | 43.2K | 473,517 | — | ↗ |
| 2021-03-15 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 12,500 | 7.41 | 92.6K | 25,000 | — | ↗ |
| 2021-02-22 | Wiley Matthew T. | Officer | A-Award | A | Stock Options | 64,575 | 8.33 | 537.9K | 64,575 | — | ↗ |
| 2021-02-22 | Stuart Iain | Officer | A-Award | A | Stock Options | 68,162 | 8.33 | 567.8K | 68,162 | — | ↗ |
| 2021-02-22 | Saik Andrew | Officer | A-Award | A | Common Stock | 29,213 | 0.00 | — | 114,213 | — | ↗ |
| 2021-02-22 | Harsch Mutya | Officer | A-Award | A | Common Stock | 29,213 | 0.00 | — | 110,638 | — | ↗ |
| 2021-02-22 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 153,750 | 0.00 | — | 479,833 | — | ↗ |
| 2021-01-28 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 4,219,409 | 2.37 | 10.00M | 27,095,819 | — | ↗ |
| 2020-12-31 | Wiley Matthew T. | Officer | F-InKind | D | Common Stock | 1,541 | 1.58 | 2.4K | 357,181 | — | ↗ |
| 2020-12-31 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,378 | 1.58 | 3.8K | 286,262 | — | ↗ |
| 2020-12-31 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,822 | 1.58 | 2.9K | 325,703 | — | ↗ |
| 2020-12-31 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 9,656 | 1.58 | 15.3K | 1,304,334 | — | ↗ |
| 2020-12-03 | LEPORE PATRICK G | Director | P-Purchase | A | Common Stock | 50,000 | 1.71 | 85.4K | 50,000 | — | ↗ |
| 2020-11-30 | Wiley Matthew T. | Officer | A-Award | A | Common Stock | 7,838 | 1.45 | 11.3K | 358,722 | — | ↗ |
| 2020-11-30 | Harsch Mutya | Officer | A-Award | A | Common Stock | 10,460 | 1.45 | 15.1K | 327,525 | — | ↗ |
| 2020-11-30 | Domzalski David | Director / Officer | A-Award | A | Common Stock | 4,263 | 1.45 | 6.2K | 1,313,990 | — | ↗ |
| 2020-09-30 | Wiley Matthew T. | Officer | F-InKind | D | Common Stock | 1,541 | 1.66 | 2.6K | 350,884 | — | ↗ |
| 2020-09-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,378 | 1.66 | 3.9K | 288,640 | — | ↗ |
| 2020-09-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,822 | 1.66 | 3.0K | 317,065 | — | ↗ |
| 2020-09-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 6,239 | 1.66 | 10.4K | 1,309,727 | — | ↗ |
| 2020-09-10 | LEPORE PATRICK G | Director | A-Award | A | Stock Options | 45,000 | 1.46 | 65.7K | 45,000 | — | ↗ |
| 2020-09-08 | Saik Andrew | Officer | P-Purchase | A | Common Stock | 40,000 | 1.46 | 58.5K | 340,000 | — | ↗ |
| 2020-09-08 | Domzalski David | Director / Officer | P-Purchase | A | Common Stock | 75,000 | 1.38 | 103.6K | 1,315,966 | — | ↗ |
| 2020-08-20 | BARBARI SHARON | Director | M-Exempt | A | Common Stock | 75,000 | 1.48 | 111.0K | 75,000 | — | ↗ |
| 2020-08-03 | Sandoval Elisabeth | Director | A-Award | A | Stock Options | 22,500 | 1.72 | 38.7K | 22,500 | — | ↗ |
| 2020-08-03 | Bruno Anthony D | Director | A-Award | A | Stock Options | 22,500 | 1.72 | 38.7K | 22,500 | — | ↗ |
| 2020-08-03 | Bright Rex | Director | A-Award | A | Stock Options | 22,500 | 1.72 | 38.7K | 22,500 | — | ↗ |
| 2020-08-03 | Basta Steven L | Director | A-Award | A | Stock Options | 22,500 | 1.72 | 38.7K | 22,500 | — | ↗ |
| 2020-08-03 | BARBARI SHARON | Director | A-Award | A | Stock Options | 22,500 | 1.72 | 38.7K | 22,500 | — | ↗ |
| 2020-06-30 | Wiley Matthew T. | Officer | F-InKind | D | Common Stock | 1,541 | 1.73 | 2.7K | 352,425 | — | ↗ |
| 2020-06-30 | Stuart Iain | Officer | F-InKind | D | Common Stock | 2,378 | 1.73 | 4.1K | 291,018 | — | ↗ |
| 2020-06-30 | Harsch Mutya | Officer | F-InKind | D | Common Stock | 1,822 | 1.73 | 3.2K | 318,887 | — | ↗ |
| 2020-06-30 | Domzalski David | Director / Officer | F-InKind | D | Common Stock | 6,239 | 1.73 | 10.8K | 1,240,966 | — | ↗ |
| 2020-06-09 | PERCEPTIVE ADVISORS LLC | 10% Owner | P-Purchase | A | Common Stock | 2,702,702 | 1.85 | 5.00M | 22,876,410 | — | ↗ |
| 2020-05-06 | Wiley Matthew T. | Officer | A-Award | A | Common Stock | 150,000 | 0.00 | — | 353,967 | — | ↗ |
Executive team
Top executives
EBIT / Employee
-20.6K
Shares Outstanding
16.66M
Executive compensation
Executive compensation (annual)
| # | Year | Executive | Salary | Bonus | Stock award | Option award | Incentive | Other | Total | % Stock- based |
Filing |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 2024 | David Domzalski President and Chief Executive Officer | 637.6K | — | 524.3K | 436.5K | 361.5K | 13.8K | 1.97M | 48.68% | ↗ |
| 2 | 2024 | Iain Stuart Chief Scientific Officer | 455.6K | — | 145.6K | 121.3K | 172.2K | 13.8K | 908.4K | 29.38% | ↗ |
| 3 | 2024 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | 443.3K | — | 145.6K | 121.3K | 167.6K | 13.8K | 891.5K | 29.93% | ↗ |
| 4 | 2023 | David Domzalski President and Chief Executive Officer | 637.6K | 382.5K | 607.5K | 501.8K | 573.8K | 13.2K | 2.72M | 40.84% | ↗ |
| 5 | 2023 | Iain Stuart Chief Scientific Officer | 421.8K | 168.7K | 168.8K | 139.4K | 253.1K | 13.2K | 1.16M | 26.45% | ↗ |
| 6 | 2023 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | 382.6K | 168.9K | 168.8K | 139.4K | 253.3K | 13.2K | 1.13M | 27.36% | ↗ |
| 7 | 2022 | David Domzalski President and Chief Executive Officer | 637.6K | — | 190.5K | 128.0K | 325.2K | 12.2K | 1.29M | 24.63% | ↗ |
| 8 | 2022 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | 422.2K | — | 45.8K | 30.8K | 143.5K | 12.2K | 654.4K | 11.69% | ↗ |
| 9 | 2022 | Iain Stuart Chief Scientific Officer | 421.8K | — | 45.8K | 30.8K | 143.4K | 12.2K | 653.9K | 11.70% | ↗ |
| 10 | 2021 | David Domzalski President and Chief Executive Officer | 637.6K | 242.9K | 1.82M | 2.14M | — | 11.6K | 4.85M | 81.62% | ↗ |
| 11 | 2021 | David Domzalski President and Chief Executive Officer | 637.6K | — | 1.82M | 2.14M | 242.9K | 11.6K | 4.85M | 81.62% | ↗ |
| 12 | 2021 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | 405.9K | — | 345.6K | 407.0K | 142.0K | 11.6K | 1.31M | 57.36% | ↗ |
| 13 | 2021 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | 405.9K | 142.0K | 345.6K | 407.0K | — | 11.6K | 1.31M | 57.36% | ↗ |
| 14 | 2021 | Iain Stuart Chief Scientific Officer | 405.6K | — | 345.6K | 407.0K | 117.6K | 11.6K | 1.29M | 58.46% | ↗ |
| 15 | 2020 | David Domzalski President and Chief Executive Officer | 500.5K | 277.2K | 1.33M | 756.9K | — | 11.4K | 2.87M | 72.52% | ↗ |
| 16 | 2020 | Steven Basta Former President and Chief Executive Officer | 118.0K | 64.9K | — | — | — | 1.43M | 1.61M | 0.00% | ↗ |
| 17 | 2020 | Andrew Saik Chief Financial Officer and Treasurer | 309.7K | 112.5K | 644.0K | 470.3K | — | — | 1.54M | 72.52% | ↗ |
| 18 | 2020 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | 318.7K | 117.7K | 292.5K | 167.0K | — | 11.4K | 907.2K | 50.65% | ↗ |
| 19 | 2019 | Steven Basta Former President and Chief Executive Officer | 598.0K | 305.9K | 974.3K | — | — | — | 1.88M | 51.87% | ↗ |
| 20 | 2019 | Steven Basta Former President and Chief Executive Officer | 598.0K | 305.9K | 974.3K | — | — | — | 1.88M | 51.87% | ↗ |
| 21 | 2019 | Kristine Ball Former Senior Vice President, Corporate Strategy and Chief Financial Officer | 416.0K | 154.8K | 327.6K | — | — | — | 898.4K | 36.47% | ↗ |
| 22 | 2019 | Paul Kwon, M.D. Former Chief Scientific Officer | 412.0K | 153.3K | 327.6K | — | — | — | 892.9K | 36.69% | ↗ |
| 23 | 2019 | Mutya Harsch Chief Legal Officer, General Counsel and Secretary | — | — | — | — | — | — | — | — | ↗ |
| 24 | 2019 | Andrew Saik Chief Financial Officer and Treasurer | — | — | — | — | — | — | — | — | ↗ |
| 25 | 2019 | David Domzalski President and Chief Executive Officer | — | — | — | — | — | — | — | — | ↗ |
| 26 | 2018 | Steven Basta Former President and Chief Executive Officer | 580.0K | 319.0K | — | 1.71M | — | — | 2.61M | 65.50% | ↗ |
| 27 | 2018 | Steven Basta President and Chief Executive Officer | 580.0K | 319.0K | — | 1.71M | — | — | 2.61M | 65.50% | ↗ |
| 28 | 2018 | Mary Spellman, M.D. Chief Medical Officer | 386.7K | 154.7K | — | 795.3K | — | — | 1.34M | 59.50% | ↗ |
| 29 | 2018 | Kristine Ball Former Senior Vice President, Corporate Strategy and Chief Financial Officer | 400.0K | 160.0K | — | 705.5K | — | — | 1.27M | 55.75% | ↗ |
| 30 | 2018 | Kristine Ball Senior Vice President, Corporate Strategy and Chief Financial Officer | 400.0K | 160.0K | — | 705.5K | — | — | 1.27M | 55.75% | ↗ |
| 31 | 2017 | Steven Basta President and Chief Executive Officer | 555.9K | 83.4K | — | 376.7K | — | — | 1.02M | 37.07% | ↗ |
| 32 | 2017 | Kristine Ball Senior Vice President, Corporate Strategy and Chief Financial Officer | 118.0K | 53.2K | — | 825.1K | — | — | 996.3K | 82.81% | ↗ |
| 33 | 2017 | Mary Spellman, M.D. Chief Medical Officer | 139.6K | 42.2K | — | 444.6K | — | — | 626.4K | 70.98% | ↗ |
CEO compensation breakdown
Proxy statements
Recent SEC filings
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| David T. Domzalski | Chief Executive Officer, President & Director | 651.6K | male |
| Iain A. Stuart | Chief Scientific Officer | 485.5K | — |
| Mutya Harsch | General Counsel, Chief Legal Officer & Company Secretary | 472.8K | female |
| Darrell S. Rigel | Consultant | 40.2K | — |
| Tyler Zeronda | Chief Financial Officer & Treasurer | — | male |
ESG Rating
ESG Score History BIOTECHNOLOGY
Benchmark vs Sector
Senate Trading Activity
No Senate trading activity found for this company.
House Trading Activity
No House trading activity found for this company.
Market share among peers
Peer comparison — filtered group (TTM)
Your opinion
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for VYNE
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
